Detalhe da pesquisa
1.
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma.
Invest New Drugs
; 42(2): 179-184, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38372949
2.
Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration-resistant prostate cancer.
Prostate
; 83(7): 649-655, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36924119
3.
Peer-to-peer: The Social Transmission of Symptoms Online.
Ann Behav Med
; 57(7): 551-560, 2023 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036880
4.
Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions.
Int J Mol Sci
; 24(22)2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38003734
5.
On the frequency response of prestin charge movement in membrane patches.
Biophys J
; 121(12): 2371-2379, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35598044
6.
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance).
Oncologist
; 2022 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445723
7.
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer.
BMC Med
; 20(1): 112, 2022 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35331214
8.
Modulators of Kv3 Potassium Channels Rescue the Auditory Function of Fragile X Mice.
J Neurosci
; 39(24): 4797-4813, 2019 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30936239
9.
The Frequency Response of Outer Hair Cell Voltage-Dependent Motility Is Limited by Kinetics of Prestin.
J Neurosci
; 38(24): 5495-5506, 2018 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29899032
10.
Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.
Support Care Cancer
; 27(2): 383-394, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30353228
11.
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer.
Breast Cancer Res
; 20(1): 52, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29898752
12.
Characterisation of cochlear inflammation in mice following acute and chronic noise exposure.
Histochem Cell Biol
; 146(2): 219-30, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27109494
13.
Going beyond (electronic) patient-reported outcomes: harnessing the benefits of smart technology and ecological momentary assessment in cancer survivorship research.
Support Care Cancer
; 29(1): 7-10, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32844316
14.
Markers of cochlear inflammation using MRI.
J Magn Reson Imaging
; 39(1): 150-61, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23589173
15.
Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC).
BMC Urol
; 14: 55, 2014 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25062956
16.
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis.
Prostate Cancer Prostatic Dis
; 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341460
17.
Patient-derived tumor xenograft study with CDK4/6 inhibitor plus AKT inhibitor for the management of metastatic castration-resistant prostate cancer.
Mol Cancer Ther
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38442920
18.
Role of mitochondrial dysfunction and oxidative stress in sensorineural hearing loss.
Hear Res
; 434: 108783, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37167889
19.
Pharmacological Modulation of Energy and Metabolic Pathways Protects Hearing in the Fus1/Tusc2 Knockout Model of Mitochondrial Dysfunction and Oxidative Stress.
Antioxidants (Basel)
; 12(6)2023 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37371955
20.
Social communication pathways to COVID-19 vaccine side-effect expectations and experience.
J Psychosom Res
; 164: 111081, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399990